Omeprazole Articles
Schwarz gets generic Prilosec OK in USA
10 May 2001
AstraZeneca gets six months' Prilosec grace
3 May 2001
AstraZeneca investing in China and India
30 April 2001
AstraZeneca hit by slip in Losec sales
26 April 2001
Stock Commentary - Europe
26 April 2001
AstraZeneca files suit against Impax in USA
22 February 2001
InKine and P&G to co-promote Visicol in USA
22 February 2001
Merck KGaA sets out plan to become number one in core businesses
20 February 2001
40%-123% US Rx price variations found
13 February 2001
Analysts expectant on future prospects for Canada's Axcan Pharma
13 February 2001
AstraZeneca aims to expand in Japan
12 February 2001
AstraZeneca issues sales and profits slowdown warning
8 February 2001
Stock Commentary - New York
18 January 2001
AstraZeneca asthma drug approved in EU
9 January 2001
Healthy harvest of New Chemical Entities in 2000
2 January 2001
AstraZeneca wins Losec case in Canada
20 December 2000
AstraZeneca's Seroquel approved in Japan
14 December 2000
AstraZeneca says pessimism surrounding Nexium take-up is unfounded
13 December 2000
AstraZeneca and Lilly suing Cheminor
5 December 2000
AstraZeneca victory in Swedish Losec case
23 November 2000
AstraZeneca Nexium sales in Sweden rise 56% in one month
22 November 2000
HCFA backs Vermont seniors' Rx drug plan
8 November 2000
ICN Pharma profits continue to climb
7 November 2000
Latest approvals from Japan's advisory board
25 October 2000
AstraZeneca - up with events
20 October 2000
AstraZeneca's Nexium is "approvable"
11 October 2000
AstraZeneca suffers setback in Australia
10 October 2000
Bullish forecast for pharma industry from Merrill Lynch, despite patent
29 September 2000
Compare US Rx drug prices, consumers told
27 September 2000
AstraZeneca suing Mylan over Losec
13 September 2000
AstraZeneca launches Losec follow-up Nexium in the UK
12 September 2000
AstraZeneca files for US approval of OTC Losec
31 August 2000
AstraZeneca reveals UK pricing for Nexium
10 August 2000
Losec follow-up Nexium gains approval in EU
13 July 2000
AstraZeneca files US patent lawsuit against Lek
21 June 2000
AstraZeneca files suits against Eon and Impax
16 May 2000
Stock Commentary Europe
11 May 2000
Stock Commentary Europe and London
4 May 2000
AstraZeneca sees 17% 1st qtr pretax growth
3 May 2000
Stock Commentary Europe
3 April 2000
European OTC sales continue slow growth
28 March 2000
Ranbaxy seeks partner to develop asthma molecule
22 March 2000
Stock Commentary Europe
16 March 2000
China sees over-supply, low demand for drugs
16 March 2000
Concern over US DTC ad info request
15 March 2000
Swedish pharma sales rose 11.2% in 1999
6 March 2000
Andrx files for generic Claritin in USA
29 February 2000
Life after Losec at AstraZeneca
29 February 2000
AstraZeneca full-year profits up 20% as new products come good
24 February 2000
Stock Commentary New York
17 February 2000
German court refers omeprazole SPC case to Euro Court of Justice
2 February 2000
Yamanouchi's Gaster weathers patent expiry
20 January 2000
Stock Commentary Europe
16 December 1999
Shares in Altana drop on AstraZeneca filing
9 December 1999
Stock Commentary Europe
9 December 1999
AstraZeneca files for new generation PPI
6 December 1999
AstraZeneca wins Losec ruling in Israel
18 November 1999
AstraZeneca files new proton pump inhibitor - update
27 October 1999
AstraZeneca files new proton pump inhibitor
26 October 1999
AstraZeneca successfully defends omeprazole in Israeli court
21 October 1999
Stock Commentary Europe
14 October 1999
Blow to AstraZeneca's defence of Losec
13 September 1999
Stock Commentary Europe
2 September 1999
One court to deal with Prilosec patent cases
24 August 1999
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
